Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The master cytokine TGF-β mediates tissue fibrosis associated with inflammation and tissue injury. TGF-β induces fibroblast activation and differentiation into myofibroblasts that secrete extracellular matrix proteins. Canonical TGF-β signaling mobilizes Smad2 and Smad3 transcription factors that control fibrosis by promoting gene expression. However, the importance of TGF-β-Smad2/3 signaling in fibroblast-mediated cardiac fibrosis has not been directly evaluated in vivo. Here, we examined pressure overload-induced cardiac fibrosis in fibroblast- and myofibroblast-specific inducible Cre-expressing mouse lines with selective deletion of the TGF-β receptors Tgfbr1/2, Smad2, or Smad3. Fibroblast-specific deletion of Tgfbr1/2 or Smad3, but not Smad2, markedly reduced the pressure overload-induced fibrotic response as well as fibrosis mediated by a heart-specific, latency-resistant TGF-β mutant transgene. Interestingly, cardiac fibroblast-specific deletion of Tgfbr1/2, but not Smad2/3, attenuated the cardiac hypertrophic response to pressure overload stimulation. Mechanistically, loss of Smad2/3 from tissue-resident fibroblasts attenuated injury-induced cellular expansion within the heart and the expression of fibrosis-mediating genes. Deletion of Smad2/3 or Tgfbr1/2 from cardiac fibroblasts similarly inhibited the gene program for fibrosis and extracellular matrix remodeling, although deletion of Tgfbr1/2 uniquely altered expression of an array of regulatory genes involved in cardiomyocyte homeostasis and disease compensation. These findings implicate TGF-β-Smad2/3 signaling in activated tissue-resident cardiac fibroblasts as principal mediators of the fibrotic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, cultured human primary cardiac and dermal fibroblasts and immortalized cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ (refs. 19,39,40), IL-1β (ref. 41)) conditions.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“TGF-β1 activates SMAD2/3 signaling, driving pro-fibrotic gene expression and extracellular matrix deposition in cardiac fibroblasts [85].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [85]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, primary human cardiac fibroblasts, primary human dermal fibroblasts, and immortalized human cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ 20,33,34 , IL-1 β 35 ) conditions.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“While numerous studies have implicated a role for TGFβ signaling in maladaptive cardiac remodeling and scar formation in HF 20,33”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · cited 1×
“Heart failure is an increasingly prevalent disease characterized by reduced cardiac output resulting from a progressive loss of cardiomyocytes, ventricular chamber remodeling, and accumulation of interstitial fibrosis (1).”
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528 · cited 1×
“Global TGF-β activity is upregulated in diseased hearts, where one of its primary actions is directed at the resident fibroblasts to alter the fibrotic response and ventricular remodeling (47, 48).”
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew082 · Cited by 2,425 · cited 1×
“The ratio of these measures ( E/e ′ ) was used as an indicator of diastolic function (60).”
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984 · cited 1×
“Progressive cardiac fibrosis in heart failure is predominantly mediated by the tissue-resident cardiac fibroblast, which becomes activated and then differentiated into a cell type referred to as the myofibroblast (5, 6).”
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934 · cited 1×
“TGF-β is considered a “master” cytokine/growth factor produced within injured or diseased tissues, where it activates fibroblasts and facilitates ECM production (15, 16).”
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 6×
“Hence, here we used mice in which the Postn genetic locus was targeted with a tamoxifen-inducible MerCreMer (MCM) cDNA (29), and these mice were crossed with Smad2 fl/fl , Smad3 fl/fl , Smad2/3 fl/fl , and Tgfbr1/2 fl/fl targeted mice (Figure 2A).”
InfluentialSelf-citationSato, M., Muragaki, Y., Saika, S., Roberts, A. B., & Ooshima, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19270 · Cited by 831
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
Fan, D., Takawale, A., Lee, J., & Kassiri, Z. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-15 · Cited by 814
The myofibroblast: Paradigm for a mechanically active cell
Hinz, B. (2010) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.09.020 · Cited by 698 · cited 1×
“In addition to producing and secreting abundant ECM material, myofibroblasts acquire contractile activity through induction of genes such as Acta2 ( α -smooth muscle actin [ α SMA]), which allows these cells to physically remodel the ECM or scar after MI (7, 8).”
Sohal, D. S., Nghiem, M., Crackower, M. A., Witt, S. A., Kimball, T. R., Tymitz, K. M., Penninger, J. M., & Molkentin, J. D. (2001) · Circulation Research · doi:10.1161/hh1301.092687 · Cited by 695 · cited 2×
“Here, we deleted Smad2/3 from the adult heart using the α -myosin heavy chain ( α MHC) MCM-containing transgene (40) to determine whether canonical Smad2/3 signaling within cardiomyocytes might similarly affect the cardiac fibrotic response with pressure overload.”
Self-citationLeask, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.217737 · Cited by 667 · cited 1×
“TGF-β is considered a “master” cytokine/growth factor produced within injured or diseased tissues, where it activates fibroblasts and facilitates ECM production (15, 16).”
Verrecchia, F., Chu, M.-L., & Mauviel, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100754200 · Cited by 664
Kuwahara, F., Kai, H., Tokuda, K., Kai, M., Takeshita, A., Egashira, K., & Imaizumi, T. (2002) · Circulation · doi:10.1161/01.cir.0000020689.12472.e0 · Cited by 609
Smad2 role in mesoderm formation, left–right patterning and craniofacial development
Nomura, M., & Li, E. (1998) · Nature · doi:10.1038/31693 · Cited by 599 · cited 1×
“Global Smad2 –/– mice are embryonic lethal (18), whereas Smad3 –/– mice are viable and hence have been examined for alterations in the fibrotic response (8, 19–22).”
Molecular Targets in Pulmonary Fibrosis
Scotton, C. J., & Chambers, R. C. (2007) · Chest · doi:10.1378/chest.06-2568 · Cited by 538
Oka, T., Xu, J., Kaiser, R. A., Melendez, J., Hambleton, M., Sargent, M. A., Lorts, A., Brunskill, E. W., Dorn, G. W., Conway, S. J., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.149047 · Cited by 494
Self-citationOka, T., Akazawa, H., Naito, A. T., & Komuro, I. (2014) · Circulation Research · doi:10.1161/circresaha.114.300507 · Cited by 460 · cited 1×
“While endothelial cells do expand with pressure overload stimulation, it is generally less than 30% (41, 42), and this effect was the same between our 2 experimental groups with or without Smad2/3 in activated cardiac fibroblasts (Figure 5G and Supplemental Figure 6).”
Teekakirikul, P., Eminaga, S., Toka, O., Alcalai, R., Wang, L., Wakimoto, H., Nayor, M., Konno, T., Gorham, J. M., Wolf, C. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42028 · Cited by 448 · cited 2×
“…heart either used mice with global Smad3 deletion, which results in loss of SMAD3 protein in all cells (19, 26), mice with cardiac-specific deletion of Tgfbr1 or Tgfbr2 , or mice treated with systemically acting drugs or blocking antibodies that do not distinguish cell type of action (27, 28, 49).”
Self-citationCardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload
Takeda, N., Manabe, I., Uchino, Y., Eguchi, K., Matsumoto, S., Nishimura, S., Shindo, T., Sano, M., Otsu, K., Snider, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40295 · Cited by 389 · cited 1×
“Progressive cardiac fibrosis in heart failure is predominantly mediated by the tissue-resident cardiac fibroblast, which becomes activated and then differentiated into a cell type referred to as the myofibroblast (5, 6).”
Dobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X.-F., & Frangogiannis, N. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.216101 · Cited by 385 · cited 4×
“However, our results in Smad3-loxP –targeted mice in which this gene was only deleted from activated fibroblasts were consistent with data from global Smad3 –/– mice in which the cardiac fibrotic response was reduced following pressure overload or MI injury (19, 20, 26).”
InfluentialEssential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling
Bujak, M., Ren, G., Kweon, H. J., Dobaczewski, M., Reddy, A., Taffet, G., Wang, X.-F., & Frangogiannis, N. G. (2007) · Circulation · doi:10.1161/circulationaha.107.704197 · Cited by 356 · cited 4×
“However, our results in Smad3-loxP –targeted mice in which this gene was only deleted from activated fibroblasts were consistent with data from global Smad3 –/– mice in which the cardiac fibrotic response was reduced following pressure overload or MI injury (19, 20, 26).”
InfluentialKoitabashi, N., Danner, T., Zaiman, A. L., Pinto, Y. M., Rowell, J., Mankowski, J., Zhang, D., Nakamura, T., Takimoto, E., & Kass, D. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44824 · Cited by 334 · cited 4×
“Indeed, cardiomyocyte-specific deletion of Tgfbr2 from the hearts of mice blocked maladaptive responses to pressure overload stimulation, inhibiting myocyte and interstitial Smad signaling and fibrosis (27).”
InfluentialNovel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
Gourdie, R. G., Dimmeler, S., & Kohl, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.89 · Cited by 332 · cited 1×
“While the physiologic function of myofibroblasts is generally beneficial, such as during acute wound healing, sustained activation and continued generation of these cells likely underlie inappropriate developmental remodeling and a wide range of adult fibrotic diseases (9–11).”
Origin of Cardiac Fibroblasts and the Role of Periostin
Snider, P., Standley, K. N., Wang, J., Azhar, M., Doetschman, T., & Conway, S. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.201400 · Cited by 302 · cited 1×
“Importantly, peri-ostin expression is specifically induced in essentially all activated fibroblasts (myofibroblasts) of the heart with injury (30–32).”
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
Park, B. V., Freeman, Z. T., Ghasemzadeh, A., Chattergoon, M. A., Rutebemberwa, A., Steigner, J., Winter, M. E., Huynh, T. V., Sebald, S. M., Lee, S.-J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1347 · Cited by 287 · cited 1×
“LoxP-targeted Smad2/3 mice were recently described as well (58).”
Self-citationSmad3 Signaling Is Required for Epithelial-Mesenchymal Transition of Lens Epithelium after Injury
Saika, S., Kono-Saika, S., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Flanders, K. C., Yoo, J., Anzano, M., Liu, C.-Y., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63153-7 · Cited by 283 · cited 1×
“Additionally, mice lacking Smad3 were protected from chemical-induced fibrosis in the kidney (23), fibrosis of the eye (24), and angiotensin II– induced fibrosis of the vasculature (25).”
Molkentin, J. D., Bugg, D., Ghearing, N., Dorn, L. E., Kim, P., Sargent, M. A., Gunaje, J., Otsu, K., & Davis, J. (2017) · Circulation · doi:10.1161/circulationaha.116.026238 · Cited by 283 · cited 2×
“…of fibrosis-mediating genes, while noncanonical signaling such as through p38 α MAPK, which we recently showed is also critical for fibrosis (54) Abcam) along with anti-CD31 (Miltenyi Biotec, 130-097-418) or anti-Erg1 (Abcam, Ab92513), then sections were incubated with a 1:500 dilution of…”
Self-citationThe extracellular matrix: At the center of it all
Bowers, S. L. K., Banerjee, I., & Baudino, T. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.08.024 · Cited by 277 · cited 1×
“Excessive deposition of extra-cellular matrix (ECM) in heart failure directly restricts normal ventricular function by reducing wall compliance; it also reduces diffusion efficiency, promotes arrhythmia, and possibly limits regenerative efforts of cardiomyocytes (2–4).”
Kaur, H., Takefuji, M., Ngai, C. Y., Carvalho, J., Bayer, J., Wietelmann, A., Poetsch, A., Hoelper, S., Conway, S. J., Möllmann, H., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308643 · Cited by 259 · cited 1×
“Importantly, peri-ostin expression is specifically induced in essentially all activated fibroblasts (myofibroblasts) of the heart with injury (30–32).”
Essential Role of Smad3 in Angiotensin II–Induced Vascular Fibrosis
Wang, W., Huang, X. R., Canlas, E., Oka, K., Truong, L. D., Deng, C., Bhowmick, N. A., Ju, W., Bottinger, E. P., & Lan, H. Y. (2006) · Circulation Research · doi:10.1161/01.res.0000218782.52610.dc · Cited by 234 · cited 1×
“Additionally, mice lacking Smad3 were protected from chemical-induced fibrosis in the kidney (23), fibrosis of the eye (24), and angiotensin II– induced fibrosis of the vasculature (25).”
Efficient inducible Cre‐mediated recombination in Tcf21 cell lineages in the heart and kidney
Acharya, A., Baek, S. T., Banfi, S., Eskiocak, B., & Tallquist, M. D. (2011) · genesis · doi:10.1002/dvg.20750 · Cited by 167 · cited 2×
“Mice containing a knockin of a MCM cDNA into either the Postn or Tcf21 genomic loci were previously described (29, 39). α MHC-MCM transgenic mice (40) and TGF-β tTA DTG transgenic mice (56) were previously described.”
Pathological Ventricular Remodeling: Therapies: Part 2 of 2
Xie, M., Burchfield, J. S., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001879 · Cited by 153 · cited 1×
“Excessive deposition of extra-cellular matrix (ECM) in heart failure directly restricts normal ventricular function by reducing wall compliance; it also reduces diffusion efficiency, promotes arrhythmia, and possibly limits regenerative efforts of cardiomyocytes (2–4).”
Qiu, P. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.002 · Cited by 143
A multifunctional reporter mouse line for Cre‐ and FLP‐dependent lineage analysis
Yamamoto, M., Shook, N. A., Kanisicak, O., Yamamoto, S., Wosczyna, M. N., Camp, J. R., & Goldhamer, D. J. (2009) · genesis · doi:10.1002/dvg.20474 · Cited by 136 · cited 1×
“Rosa26 reporter mice ( R26 EGFP ) were previously described (57) and were purchased from the Jackson Laboratory (catalog 012429).”
Self-citationJinnin, M., Ihn, H., Asano, Y., Yamane, K., Trojanowska, M., & Tamaki, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207064 · Cited by 134
New pharmacological treatments for improving renal outcomes in diabetes
Declèves, A., & Sharma, K. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.57 · Cited by 120 · cited 1×
“Thus, inhibition of myofibroblast conversion or their activity would be an attractive therapeutic approach in adult fibrotic disease states, including heart failure (12–14).”
Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death
Karch, J. M., Kanisicak, O., Brody, M. J., Sargent, M. A., Michael, D. M., & Molkentin, J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130520 · Cited by 116
Self-citationGATA4 regulates Fgf16 to promote heart repair after injury
Yu, W., Huang, X., Tian, X., Zhang, H., He, L., Wang, Y., Nie, Y., Hu, S., Lin, Z., Zhou, B., et al. (2016) · Development · doi:10.1242/dev.130971 · Cited by 115 · cited 1×
“Also of interest, Fgf16 and Ptn are known protective factors in the heart (44–46) that were each substantially down-regulated with loss of Tgfbr1/2 (Figure 7D).”
Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta
Chen, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg224 · Cited by 113
Divakaran, V. G., Adrogue, J. V., Ishiyama, M., Entman, M. L., Haudek, S. B., Sivasubramanian, N., & Mann, D. L. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.823070 · Cited by 112 · cited 5×
“…and Tgfbr2 loci. studies, global Smad3 –/– mice showed significantly greater lethality after pressure overload stimulation, although surviving mice showed a 60% reduction in total ventricular fibrosis, with no difference in the degree of cardiac hypertrophy induction compared with controls (19).”
InfluentialFuture treatments in systemic sclerosis
Asano, Y. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00758.x · Cited by 107 · cited 1×
“Thus, inhibition of myofibroblast conversion or their activity would be an attractive therapeutic approach in adult fibrotic disease states, including heart failure (12–14).”
Christman, K. L., Fang, Q., Yee, M. S., Levental, K. R., Sievers, R. E., & Lee, R. J. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.04.025 · Cited by 93
Caspase-3 Protects Stressed Organs against Cell Death
Khalil, H., Peltzer, N., Walicki, J., Yang, J.-Y., Dubuis, G., Gardiol, N., Held, W., Bigliardi, P. L., Marsland, B. J., Liaudet, L., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00774-12 · Cited by 92 · cited 1×
“Western blotting was performed as described previously (61).”
Self-citationAccornero, F., van Berlo, J. H., Correll, R. N., Elrod, J. W., Sargent, M. A., York, A. J., Rabinowitz, J. E., Leask, A., & Molkentin, J. D. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00199-15 · Cited by 82 · cited 1×
“To confirm and extend our observations to this point, a cardiac-specific, latency-escaping mutant TGF-β – expressing (TGF-β 1 Cys223,225Ser ) transgene was used, which we previously showed induces interstitial cardiac fibrosis (43).”
Self-citationZhang, L., Liu, C., Meng, X., Huang, C., Xu, F., & Li, J. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2258-1 · Cited by 73 · cited 2×
“In hepatic stellate cells (fibroblasts), knockdown of Smad3 reduced TGF-β –induced type 1a collagen expression while knockdown of Smad2 increased its expression and Smad2 overexpression reduced type 1a collagen expression (52).”
Hepatic fibrogenesis: From within and outwith
Henderson, N. C., & Forbes, S. J. (2008) · Toxicology · doi:10.1016/j.tox.2008.08.017 · Cited by 71 · cited 1×
“While the physiologic function of myofibroblasts is generally beneficial, such as during acute wound healing, sustained activation and continued generation of these cells likely underlie inappropriate developmental remodeling and a wide range of adult fibrotic diseases (9–11).”
Ramirez, A. M., Shen, Z., Ritzenthaler, J. D., & Roman, J. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01430.x · Cited by 66 · cited 1×
“Global Smad2 –/– mice are embryonic lethal (18), whereas Smad3 –/– mice are viable and hence have been examined for alterations in the fibrotic response (8, 19–22).”
Gut-Enriched Krüppel-Like Factor Interaction with Smad3 Inhibits Myofibroblast Differentiation
Hu, B., Wu, Z., Liu, T., Ullenbruch, M. R., Jin, H., & Phan, S. H. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0043oc · Cited by 64
Synergistic roles of scleraxis and Smads in the regulation of collagen 1α2 gene expression
Bagchi, R. A., & Czubryt, M. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.07.002 · Cited by 64 · cited 2×
“Because Smad2 and Smad3 are transcription factors that have been implicated in directly mediating expression of myofibroblast genes (17, 20, 33–38), we assessed mRNA levels of endogenous Postn , Col1a1 , and Col3a1 from primary cardiac fibroblasts treated with TGF-β in culture.”
Identification of the gene transcription and apoptosis mediated by TGF‐β‐Smad2/3‐Smad4 signaling
Yu, J., Zhang, L., Chen, A., Xiang, G., Wang, Y., Wu, J., Mitchelson, K. R., Cheng, J., & Zhou, Y. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21325 · Cited by 62 · cited 2×
“Finally, transcriptional profiling in Hep3B cells showed that knockdown of Smad2 versus Smad3 resulted in 190 genes being differentially controlled, and again, Smad3 was dominant over Smad2 in how TGF-β affected these cells (53).”
Pleiotrophin induces formation of functional neovasculature in vivo
Christman, K. L., Fang, Q., Kim, A. J., Sievers, R. E., Fok, H. H., Candia, A. F., Colley, K. J., Herradón, G., Ezquerra, L., Deuel, T. F., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.174 · Cited by 60 · cited 1×
“Also of interest, Fgf16 and Ptn are known protective factors in the heart (44–46) that were each substantially down-regulated with loss of Tgfbr1/2 (Figure 7D).”
Strategies for TGF-β modulation: a review of recent patents
Bonafoux, D., & Lee, W. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903397400 · Cited by 57
Bai, G., Hock, T., Logsdon, N. J., Zhou, Y., & Thannickal, V. J. (2014) · Gene · doi:10.1016/j.gene.2014.02.026 · Cited by 55
Accornero, F., Kanisicak, O., Tjondrokoesoemo, A., Attia, A. C., McNally, E. M., & Molkentin, J. D. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu413 · Cited by 54 · cited 1×
“Mice containing a knockin of a MCM cDNA into either the Postn or Tcf21 genomic loci were previously described (29, 39). α MHC-MCM transgenic mice (40) and TGF-β tTA DTG transgenic mice (56) were previously described.”
Self-citationLiu, R., Correll, R. N., Davis, J., Vagnozzi, R. J., York, A. J., Sargent, M. A., Nairn, A. C., & Molkentin, J. D. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.08.018 · Cited by 50 · cited 1×
“For analysis of longitudinal strain and diastolic function by echocardiography, a Vevo 2100 instrument with 18–38 MHz transducer (VisualSonics) was used as previously described (59).”
Self-citationde Kroon, L. M. G., Narcisi, R., van den Akker, G., Vitters, E. L., Davidson, E. N. B., van Osch, G. J. V. M., & van der Kraan, P. M. (2017) · Scientific Reports · doi:10.1038/srep43164 · Cited by 48 · cited 1×
“For example, Smad3 dominates over Smad2 in regulating TGF-β –dependent chondrogenic differentiation (50).”
Anversa, P., Capasso, J. M., Ricci, R., Sonnenblick, E. H., & Olivetti, G. (1989) · PubMed · Cited by 25
Rosenbloom, J., Ren, S., & Macarak, E. J. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.011 · Cited by 24 · cited 2×
“Thus, targeting one aspect of TGF-β signaling as an antifibrotic approach might circumvent the known ineffectualness associated with drugs or antibodies that globally block TGF-β signaling (55).”
Gong, K., Chen, M., Li, R., He, Y., Zhu, H., Yao, D., Oparil, S., & Zhang, Z. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453149 · Cited by 10 · cited 1×
“Moreover, Smad3, but not Smad2, is part of a transcriptional regulatory complex with histone deacetylase-1 (HDAC1) in binding to the PPAR γ promoter in mouse cardiac fibroblasts (51).”
Cited by
CAR T cells produced in vivo to treat cardiac injury
Rurik, J. G., Tombácz, I., Yadegari, A., Méndez Fernández, P. O., Shewale, S. V., Li, L., Kimura, T., Soliman, O. Y., Papp, T. E., Tam, Y. K., et al. (2022) · Science · doi:10.1126/science.abm0594 · Cited by 1,400
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,278
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
CAR T Cells Produced in vivo to Treat Cardiac Injury
Rurik, J. G., Tombácz, I., Yadegari, A., Fernández, P. O. M., Shewale, S. V., Li, L., Kimura, T., Soliman, O. Y., Papp, T. E., Tam, Y. K., et al. (2023) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/mono/978-81-19039-63-0/ch19 · Cited by 929
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Metadata
- Authors
- Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., Karch, J., & Molkentin, J. D.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Johns Hopkins University (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-09-11
- Volume
- 127
- Issue
- 10
- Pages
- 3770-3783
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5617658
- OpenAlex
- W2750808153
- Cited by
- 905
- References
- 64
- Citations by year
- 2026: 92 · 2025: 102 · 2024: 128 · 2023: 121 · 2022: 144 · 2021: 110 · 2020: 84 · 2019: 85 · 2018: 34 · 2017: 2
- FWCI
- 43.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Language arts journal of Michigan (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (158486, 148429)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL069779, R01HL105924)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060636)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- myocardial fibrosis, TGF-beta signaling, Smad2, Smad3, cardiac fibroblasts, myofibroblasts, TGF-beta receptor, pressure overload, cardiac hypertrophy, extracellular matrix remodeling
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type I, Receptor, Transforming Growth Factor-beta Type II, Animals, Fibrosis, Heart Diseases, Male, Mice, Transgenic, Myocardium, Organ Specificity, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Myocytes, Cardiac, Mice, Smad2 Protein, Smad3 Protein, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.